Breast regimen-specific consent forms

Dear All,

 

I am pleased to inform you that the breast regimen-specific consent forms have been updated with the following:

  • Subcutaneous administration option for regimens containing Trastuzumab  and Pertuzumab.
  • Standard  statement on alcohol to regimens containing Gemcitabine and Paclitaxel.
  • Standard statement indicating the risk of diabetes with SACT treatment, including those where steroids are in the protocol for anti-emetic/allergy.

The forms are available via CRUK website at: www.cruk.org/sact_consent.

Please forward to your colleagues.

Any questions please let me know.

 

Best wishes,

Alia

Alia Nizam |Specialist Oncology Pharmacist. CRUK – Information Lead|

Guy’s and St Thomas’ NHS Foundation Trust

Guy’s Hospital | Great Maze Pond | London | SE1 9RT
SACT regimen-specific consent forms: www.cruk.org/sact consent |

Our values: Put patients first | Take pride in what we do | Respect others | Strive to be the best | Act with integrity

 

Latest News

By BOPA Executive Committee on 30th October 2026

Publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs

We are delighted to recognise the recent publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs, a new book bringing together expertise from oncology pharmacy professionals across the world.…

Read article
By BOPA Executive Committee on 30th October 2026

Acute and Supportive Oncology Clinical Consensus Statement

BOPA welcomes the Acute and Supportive Oncology Clinical Consensus Statement, to which we were pleased to contribute. It will be a benchmark for the sector, bringing direction and consistency as…

Read article
By BOPA, COSA, CAPhO & ISOPP on 13th October 2026

International Debate Webinar: Eastern and Western Medicine Can Co-exist – part of London Global Cancer Week 2026

Monday 2 November 2026 | 21:00 GMT (check your local time) Part of London Global Cancer Week 2026 Can Eastern and Western medicine co-exist in modern cancer care? Or do…

Read article
By Joseph Williams on 8th October 2026

BOPA 2026 Mentioned in Pharmaceutical Journal

Invest in aseptic services for future of specialised medicines, says chief pharmacist – The Pharmaceutical Journal Aseptic facilities are “absolutely essential” for hospitals to be involved in clinical trials and…

Read article